AB075. SOH25_AB_276. Ultra-distal bypass remains a valuable option for tibial disease with tissue loss—a case series
Vascular Session

AB075. SOH25_AB_276. Ultra-distal bypass remains a valuable option for tibial disease with tissue loss—a case series

Waad Ahmed, Megan Power Foley, Seamus McHugh, Sayed Aly, Peter Naughton, Daragh Moneley, Elrasheid Kheirelseid

Department of Vascular Surgery, Beaumont Hospital, Dublin, Ireland


Background: The pattern of distal tibial calcific disease associated with chronic kidney disease (CKD) and diabetes is challenging to revascularize. Ultra-distal bypass, on to pedal or plantar vessels, is an option for patients who have failed an endovascular approach. The goal of such ultra-distal bypasses is often to achieve wound healing rather than long-term patency. We present a case series from an Irish tertiary vascular centre.

Methods: A retrospective review of all ultra-distal bypasses since 2019 was performed. Cases were identified from theatre logs. Electronic health records and formal charts were used to record demographics, comorbidities and outcomes. Statistical analysis was performed using SPSS (Statistical package for social sciences).

Results: Since 2019, 25 limbs in 23 patients underwent ultra-distal bypass for tissue loss, 16 to pedal vessels and 9 to plantars. All patients were male and median age was 62.0 years (range, 43–85 years). Seventy-two percent (n=18) of the cohort were diabetic, 9 (36%) had CKD, 4 (16%) were dialysis-dependent and 5 (20%) had congestive heart failure. Median follow-up duration was 14 months (range, 0–51 months). At 12 months, freedom from graft failure was 68% (n=17) and freedom from major amputation was 92% (n=23). At most recent clinic review, 85% (n=17) of wounds had healed.

Conclusions: Ultra-distal bypasses are a valuable tool in a vascular surgeon’s arsenal for tissue loss in patients with complex tibial disease. Though the durability of bypass was variable, the majority of patients included in this study healed their ulcers and only three limbs progressed to major amputation.

Keywords: Chronic kidney disease (CKD); diabetic; distal bypass; patency; wound


Acknowledgments

None.


Footnote

Funding: None.

Conflicts of Interest: The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


doi: 10.21037/map-25-ab075
Cite this abstract as: Ahmed W, Foley MP, McHugh S, Aly S, Naughton P, Moneley D, Kheirelseid E. AB075. SOH25_AB_276. Ultra-distal bypass remains a valuable option for tibial disease with tissue loss—a case series. Mesentery Peritoneum 2025;9:AB075.

Download Citation